Published • loading... • Updated
BioNTech: Profit Logic Puts German Vaccine Production at Risk
Summary by Perspektive
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The German pharmaceutical company BioNTech is shrinking dramatically. Several plants will be closed and sold. Thousands are now potentially losing their jobs and German vaccine production is entering the Bredouille. – A comment by Vinzent Kassel. The Mainz pharmaceutical company BioNTech is massively dismantling jobs. A total of 1,860 workers are to be affected by these measures by the end of next year. Entire plants are to be closed. Among them…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
